Song Jin Hwa, Kim Youlim
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
Division of Pulmonary and Allergy, Department of Internal Medicine, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Republic of Korea.
Tuberc Respir Dis (Seoul). 2025 Jan;88(1):1-13. doi: 10.4046/trd.2024.0040. Epub 2024 Sep 23.
Spirometry can play a critical role as a gold standard in the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD). While the criteria for diagnosis have advanced over time, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) standard of the forced expiratory volume in 1 second/forced vital capacity ratio <0.7 remains the most universally employed metric. However, spirometry cannot be utilized in all situations, and test execution can be difficult for some patients, often showing normal values in the early diagnosis of COPD. Therefore, research on new diagnostic methods is underway. Techniques include whole-body plethysmography for measurement of residual volume and inspiratory capacity and airway resistance, diffusing capacity of carbon monoxide or nitric oxide, impulse oscillometry, infrared time-offlight depth image sensor, diaphragm ultrasonography, which can enable early diagnosis and multifaceted assessment of patients with COPD.
肺量计作为慢性阻塞性肺疾病(COPD)患者诊断和治疗的金标准,可发挥关键作用。虽然诊断标准随着时间推移有所进步,但全球慢性阻塞性肺疾病倡议(GOLD)的1秒用力呼气量/用力肺活量比值<0.7这一标准仍是最普遍采用的指标。然而,肺量计并非在所有情况下都能使用,而且对一些患者来说测试执行可能困难,在COPD早期诊断中常显示正常数值。因此,新诊断方法的研究正在进行。这些技术包括用于测量残气量、吸气量和气道阻力的全身体积描记法、一氧化碳或一氧化氮弥散量、脉冲振荡法、红外飞行时间深度图像传感器、膈肌超声检查,这些方法能够实现COPD患者的早期诊断和多方面评估。